The Current state of Chest pain triage

The Problem

There are as many as 8 million visits to the ER per year due to chest pain.¹ However, determining whether or not the cause of chest pain is due to Coronary Artery Disease or Acute Coronary Syndrome is a complex process for physicians.² Many patients will undergo multiple layers of diagnostic testing to minimize the risk of a missed cardiac event, which can be time consuming and expensive.

Challenges with Chest Pain Triage

Blue hour glass icon illustrating the long wait times at hospitals.
Length of stay

Patients entering the hospital for chest pain may be kept for an 8-23 hour stay.³ Long hospital stays are currently needed to rule out the possibility of a major adverse cardiac event. 

Blue heart and computer monitor icon illustrating the various tests that chest pain patients are subject to.
Wide Range of Testing

There are many diagnostic tests that patients may go through to find the cause of their chest pain. These include various types of stress tests that can involve pharmaceutical or exercise-based stress.

Blue dollar sign representing the high costs associated with chest pain triage.
High Costs

The many diagnostic tests plus long hospital stays make this triage process very expensive.⁴ This cost is felt by both hospitals and patients.

Risks of Chest Pain Triage

Entrance sign to a hospital with the building and blue sky in the background.

Misdiagnosing patients with chest pain may result in inadvertent or premature discharge from the hospital. The risk of under-treating a patient with chest pain is a possible major adverse cardiac event (MACE). Many of these patients will not have a MACE.⁵ Despite this, patients are kept in the hospital under observation to minimize the possibility of under treating someone who needs further treatment. This practice raises both the cost of care and the patient’s length of stay in the hospital

Doctor monitoring a computer while patient performs a stress test.

Over treatment of patients with chest pain may include unnecessary invasive diagnostic testing or procedures. Since many of these patients will ultimately not experience any major adverse cardiac events, it is important to provide serious medical treatment only to those who need it. There is a high risk of over treating because it is difficult to rapidly rule out the patients who are not in need of invasive procedures like cardiac catheterization. 

Our MCG Solutions

CardioFlux Magnetocardiograph™

CardioFlux Magnetocardiograph (MCG) is a FDA Cleared, non-invasive biomagnetic imaging system that requires no exercise or patient exposure to radiation. Leveraging over forty years of clinical investigation, CardioFlux MCG is intended for use as a tool to measure and display the magnetic signals produced by your heart.

Faraday Analytical Cloud™

CardioFlux MCG is powered by Faraday Analytical Cloud, the software that generates images of the patient’s magnetic field. Physicians can order scans and have the results within minutes through integrating Faraday with a hospital’s clinical and administrative systems.